Home Blog Nemep President John Quinlan Hosts Candidate Joe Sempolinski

NEMEP President John Quinlan Hosts Candidate Joe Sempolinski

Yesterday, John Quinlan of Quinlan’s Pharmacy hosted an event with candidate Joe Sempolinski, who is running in New York’s 23rd district replacing Tom Reed, who is not seeking another term in 2022.

Quinlan and the group discussed DMEPOS concerns with the candidate, including the need to release the DMEPOS Final Rule and extend Cares Act reimbursement for non-rural and rural areas, and to establish new rates for competitive bid areas due to increase costs of equipment, PPE, surcharges, and increased labor costs. The group also discussed the need to fix the supply chain issues at our ports and create a plan to manufacturer more in the USA.

(Represented from left to right: John Gallagher, VP of VGM Government Relations; State Assemblywoman Marjorie Byrnes; John Quinlan, President of NEMEP and Quinlan's Pharmacy & Medical Supply; Eric Worden, Quinlan’s Medical Equipment Director of DME Operations; Candidate Joe Sempolinski for District 23; Kevin Greuber Quinlan’s Pharmacy Director of Operations; Dr. Chad Teeters, CEO UR Noyes Health and Medical Director of AHP; and Frank Steed, President of Gerould's Healthcare.)

John Gallagher also attended the event and reports, “I was very impressed with candidate Joe Sempolinski and the two hours he took listening, asking questions, taking notes, and trying to understand what is happening to healthcare access in his potential rural NY district.”

Gallagher adds, “John Quinlan did an outstanding job of inviting a diverse group of healthcare providers (hospital administrator, pharmacy, DME, nursing, etc.) to discuss what is happening with supply chain, staffing, and Medicare & Medicaid issues. It is critical that we as an industry follow John Quinlan’s lead and educate early on future political leaders on DME and how we are an integral cog in the continuum of quality, post-acute healthcare!”

Thank you to all who attended and/or supported this event.

0 comments